Zealand Pharma, Generate Strike AI Obesity Drug Deal Worth up to $1.2 Billion

Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion - Regional Media News

Oct 13 (Reuters) - Danish obesity-drug developer Zealand Pharma has partnered with US biotechnology company Generate Biomedicines to develop protein-based treatments for obesity and other metabolic diseases using AI, in a deal worth up to $1.2 billion. Generate will receive $30 million upfront and up [...]

Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion

Oct 13 (Reuters) - Zealand Pharma and Generate Biomedicines said ​on Tuesday they ‌have partnered to develop protein-based treatments for obesity and other ‌metabolic ​diseases using ⁠AI, in a ⁠deal worth up to nearly $1.2 billion. Shares of Somerville...

Zealand Pharma taps Generate's AI in obesity deal worth up to $1.2 billion

Zealand's AI-driven obesity drug collaboration could redefine treatment strategies, emphasizing multispecific proteins for complex conditions.

Zealand Pharma Makes Deal With Generate Worth Up to $1.2 Billion

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.